Multiple Myeloma
Multiple Myeloma (MM) is a type of cancer that forms in plasma cells, a kind of white blood cell found in the bone marrow. It leads to the production of abnormal proteins and can cause damage to bones and organs.
Dexamethasone for Advanced Multiple Myeloma
We are studying a free treatment regimen of Dexamethasone for patients with advanced relapsed or refractory multiple myeloma. The goal is to see how well it works in improving response rates and quality of life.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Have you received between 1 to 3 prior treatments for multiple myeloma (MM)?
- Are you currently pregnant or breastfeeding?
- Do you have any serious heart problems or uncontrolled lung disease?
- Have you had any other cancers in the last 3 years, except for certain skin cancers?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Centre Hospitalier D'Abbeville
Service Médecine Interne
Abbeville, France
Centre Hospitalier Du Pays D Aix Centre Hospitalier Intercommunal Aix-Pertuis
ONCO HEMATOLOGIE MEDECINE INTERNE
Aix-en-Provence, France
Centre Hospitalier Annecy Genevois
HEMATOLOGIE
Annecy, France
Sponsor: Assistance Publique Hopitaux De Paris
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.